Abstract:5182 Bcl-2 family of proteins are over-expressed in many cancers including leukemia and lymphoma, and it’s now recognized that overexpression of Bcl-2 family proteins plays an important role in the resistance to current anti-cancer therapies and is associated with unfavorable outcome. Gossypol is a polyphenolic aldehyde occurring naturally in cottonseed that has been extensively investigated as a male contraceptive agent, was recently discovered as a potent pan inhibitor of Bcl-2 family proteins. To overcome the potential non-specific toxicity related to the two reactive aldehyde groups in gossypol, we designed and synthesized a novel apogossypolone (ApoG2) in which the two aldehyde groups of gossypol are completely removed. We showed previously that ApoG2 exhibited more potent binding to Bcl-2 proteins, with Ki value of 25 nM for Mcl-1, Ki value of 35 nM for Bcl-2, respectively. In this study, we compared the stability, tolerance and antiproliferation effects in four human leukemia and lymphoma cells (HL-60, U937, K562, and Raji). Each sample of stability tests was evaluated for spectral purity using a proposed HPLC method and an HPLC system equipped with UV detector. The results showed that ApoG2 is very stable in the solid states upon standing at room temperatures for at least three weeks, and in various vehicles such as CMC (carboxymethylcellulose), DMSO and sesame oil. More importantly, when gossypols and ApoG2 were subjected to stress conditions of acid, base, peroxide and light, ApoG2 is the only stable compound resistant to acid, base, peroxide and light among gossypol and gossypol derivatives. The cytotoxicity was assessed in cell cultures derived from leukaemia and lymphoma using the tetrazolium-based WST viability assay. ApoG2 induced a dose-dependent cell killing effect in all cell lines with a mean IC50 of 1-3 μM at 72 hours and was significantly more potent than the racemic gossypol. In vitro, ApoG2 also demonstrated strong synergy with various kinase inhibitors in multiple cancer cell lines. Furthermore, ApoG2 was investigated in both mice and rats for maximal tolerated dose (MTD), and the data indicate that ApoG2 was significantly more tolerable than gossypol with MTD dose at more than 2,000 mg/kg level in a multi-dosing schedule. Preliminary studies using one gastric cancer xenograft model showed that ApoG2 is orally active against tumor proliferation in vivo. These investigations suggest that a novel and potent derivative of gossypol without aldehyde functional groups such as ApoG2 may have therapeutic potential for human leukemia/lymphoma and solid tumors either as a single agent or in a combination regimen.

Gossypol with Hydrophobic Linear Esters Exhibits Enhanced Antitumor Activity As an Inhibitor of Antiapoptotic Proteins.

A Novel Water-Soluble Gossypol Derivative Increases Chemotherapeutic Sensitivity and Promotes Growth Inhibition in Colon Cancer

A Novel Pan Inhibitor of Bcl-2 and Mcl-1 Apogossypolone (apog2) with Superior Stability and Improved Activity Against Human Leukemia and Lymphoma Cells.

Natural Product Gossypol and Its Derivatives in Precision Cancer Medicine

Gossypol Has Anti-Cancer Effects by Dual Targeting Mdm2 and Vegf in Human Breast Cancer

Anti-tumor compounds identification from gossypol Groebke imidazopyridine product

Gossypol induces apoptosis of human pancreatic cancer cells via CHOP/endoplasmic reticulum stress signaling pathway

Design, Synthesis and Evaluation of Novel Apogossypol Derivatives Targeting Anti-Apoptotic Bcl-2 Family Proteins

A Liposomal Delivery Vehicle for the Anticancer Agent Gossypol.

A novel bioavailable BH3 mimetic efficiently inhibits colon cancer via cascade effects of mitochondria.

Chiral Gossypol Derivatives: Evaluation of Their Anticancer Activity and Molecular Modeling.

Molecular Mechanism of Gossypol-Induced Cell Growth Inhibition and Cell Death of HT-29 Human Colon Carcinoma Cells.

Synergistic cytotoxicity of Bcl-xL inhibitor, gossypol and chemotherapeutic agents in non-Hodgkin’s lymphoma cells

In Vitro Effects of the BH3 Mimetic, (−)-Gossypol, on Head and Neck Squamous Cell Carcinoma Cells

Synthesis and Biological Evaluation of a Novel Apogossypolone Derivative

A Novel Synthesis Method of Apogossypolone and Its Antitumor Activity

ApoG2 as the most potent gossypol derivatives inhibits cell growth and induces apoptosis on gastric cancer cells.

In Vitro and in Vivo Efficacy and Toxicity Comparison Between ApoGossypol and Gossypol, Bcl-2 Antagonists

Gossypol and Its Natural Derivatives: Multitargeted Phytochemicals as Potential Drug Candidates for Oncologic Diseases

The potential roles of gossypol as anticancer agent: advances and future directions

Preclinical Efficacy and Toxicity Analysis of the Pan-Histone Deacetylase Inhibitor Gossypol for the Therapy of Colorectal Cancer or Hepatocellular Carcinoma